Home/Filings/4/0001061983-25-000049
4//SEC Filing

Callos Andrew 4

Accession 0001061983-25-000049

CIK 0001061983other

Filed

Dec 7, 7:00 PM ET

Accepted

Dec 8, 5:28 PM ET

Size

7.9 KB

Accession

0001061983-25-000049

Insider Transaction Report

Form 4
Period: 2025-12-08
Callos Andrew
EVP, Chief Commercial Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2025-12-08$39.13/sh+1,042$40,77351,702 total
  • Sale

    Common Stock

    2025-12-08$65.96/sh1,042$68,73050,660 total
  • Exercise/Conversion

    Non-Qualified Stock Option (Right to Buy)

    2025-12-081,04235,403 total
    Exercise: $39.13From: 2023-04-06Exp: 2033-03-06Common Stock (1,042 underlying)

Issuer

CYTOKINETICS INC

CIK 0001061983

Entity typeother

Related Parties

1
  • filerCIK 0001852129

Filing Metadata

Form type
4
Filed
Dec 7, 7:00 PM ET
Accepted
Dec 8, 5:28 PM ET
Size
7.9 KB